Background
Methods
Participants/ study population
Data collection
Ethics
Enteral nutrition policy
Cohort 1 | Cohort 2 | |
---|---|---|
Start of enteral feeds within 4 h of birth | 10–15 ml/kg/d | 20 ml/kg/d |
Increase in daily enteral feeding volume | 15–20 ml/kg/day | 25–30 ml/kg/day |
Cut-off for of gastric residual volume considered “normal” (in infants with unremarkable abdominal clinical status) | 1–2 ml/kg | < 4 ml/kg |
Start of breast milk fortification (FM85, Nestle, Frankfurt) at enteral feeding intake | ≥150 ml/kg/d | ≥100 ml/kg/d |
Parenteral protein administration (day1) | 2.5 g/kg/day | 3.0 g/kg/d |
Calculation of standard deviation scores (SDS) for weight (SDSW), length (SDSL) and head circumference (SDSHC)
Statistical analyses
Results
Participants
Cohort 1 n = 84 | Cohort 2 n = 61 | ||
---|---|---|---|
Female | n (%) | 48 (57%) | 38 (62%)e |
Gestational age at birth (weeks) | Median (Q1, Q3) | 26.1 (24.9–27.6) | 27.0 (26.0–27.7)e |
Birth weight (g) | Median (Q1, Q3) | 740 (597–932) | 785 (620–980) |
Birth length (cm) | Median (Q1, Q3) | 33 (31–35) | 33 (31–35) |
Birth head circumference (cm) | Median (Q1, Q3) | 22.5 (22.0–25.0) | 24.0 (22.5–25.7) |
Infants from multiple pregnancies | n (%) | 22 (26.2%) | 36 (59.0%)e |
Twins | n (%) | 18 (21.4%) | 28 (45.9%) |
Triplets | n (%) | 4 (4.8%) | 8 (13.1%) |
Length of hospital stay (days) | Median (Q1, Q3) | 89 (64–109) | 77 (55–102) |
Postmenstrual age at discharge (weeks) | Median (Q1, Q3) | 39.3 (37.2–41.0) | 38.4 (36.0–40.7) |
Neonatal morbidities | |||
Necrotizing enterocolitisb | n (%) | 2 (2.4%) | 2 (3.3%) |
Focal intestinal perforation | n (%) | 5 (6.0%) | 2 (3.3%) |
Intraventricular hemorrhage ≥III | n (%) | 7 (8.3%) | 2 (3.3%) |
Periventricular leukomalacia | n (%) | 1 (1.2%) | 3 (4.9%) |
Bronchopulmonary dysplasiaa | n (%) | 21 (25%) | 14 (23%) |
Retinopathy of Prematurity requiring therapy | n (%) | 8 (9.5%) | 2 (3.2%) |
Total time withc | |||
Peripheral venous line (days) | Median (Q1, Q3) | 11 (7–19) | 9 (5–15)e |
Central venous line (days) | Median (Q1, Q3) | 6 (0–14) | 0 (0–6)e |
Antibiotic treatment (days) | Median (Q1, Q3) | 10 (5–22) | 9 (5–17) |
Nutrition | |||
Day of life when full enteral feeds were attained | Median (Q1, Q3) | 9 (8–11) | 7 (6–9)e |
Cumulative protein intake (g/kg) | |||
First postnatal week | Median | 25.5 (23.4–27.0) | 24.2 (22.3–27.3) |
First postnatal 28 days | (Q1, Q3) | 104.6 (99.8–108.1) | 109.0 (103.1–115.0)e |
Cumulative parenteral protein intake (g/kg) | |||
First postnatal week | Median (Q1, Q3) | 17.9 (15.7–20.0) | 10.7 (8.3–15.0)e |
First postnatal 28 days | Median (Q1, Q3) | 22.8 (17.1–30.3) | 12.8 (8.3–22.7)e |
Cumulative energy intake (kcal/kg) | |||
First postnatal week | Median (Q1, Q3) | 592 (529–625) | 653 (577–721)e |
First postnatal 28 days | Median (Q1, Q3) | 3358 (3109–3490) | 3442 (3266–3673)e |
Nutrition at discharge | |||
Mother’s own milkd 100% | n (%) | 25 (30%) | 32 (53%)e |
Mother’s own milkd & Formula | n (%) | 18 (21%) | 14 (23%) |
Formula 100% | n (%) | 41 (49%) | 15 (25%)e |
Nutrition at 3 months follow up | n = 67 | n = 54 | |
Mother’s own milkd 100% | n (%) | 6 (9%) | 11 (20%) |
Mother’s own milkd & Formula | n (%) | 10 (15%) | 6 (11%) |
Formula 100% | n (%) | 51 (76%) | 37 (69%) |
Duration of expressed breast milk/breastfeeding (months) | n = 39 | n = 45 | |
Based on questionnaire | Median (Q1, Q3) | 5 (3–9) | 5 (4–9) |
Time | Cohort 1 | Cohort 2 | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Weight (kg) | SDS weight | SDS length/height | SDS head circumference | SDS BMI | n | Weight (kg) | SDS weight | SDS length/height | SDS head circumference | SDS BMI | |
Birth | 84 | 0.740 (0.597–0.932) | − 1.17 (− 2.09 - -0.23) | N/A | − 1.39 (− 2.04 - -0.50) | N/A | 61 | 0.785 (0.620–0.980) | − 1.40 (− 2.24 - -0.61) | N/A | − 1.16 (− 2.06 - -0.52) | N/A |
Discharge | 84 | 2.692 (2.370–3.044) | − 1.24 (− 2.01 - -0.69) | − 2.24 (− 3.17 - -1.58) | − 0.72 (− 1.55–0.09) | 0.27 (− 0.38–1.02) | 61 | 2.530 * (2.028–2.858) | − 1.42 (− 2.35 - -0.68) | −2.65 (− 3.39 - -1.75) | −1.17* (− 2.06 - -0.76) | 0.18 (− 0.41–1.01) |
S1 (6–7 months) | 74 | 5.22 (4.74–5.85) | − 1.47 (− 2.21 - -0.77) | −1.31 (− 1.85 - -0.41) | −0.81 (− 1.7 - -0.10) | −1.09 (− 1.72 - -0.36) | 56 | 5.02 (4.56–5.80) | −1.84 (− 2.54 - -0.81) | −1,35 (− 2.25 - -0.26) | −1.19 (− 2.02 - -0.49) | −1.52 (− 2.16 - -0.46) |
S2 (10–12 months) | 74 | 7.31 (6.66–8.21) | −1.68 (− 2.62 - -1.00) | −0.75 (− 1.26–0.18) | − 1.40 (− 2.22 - -0.85) | −1.67 (− 2.8 - -0.98) | 52 | 7.09 (6.29–7.98) | −2.07 (− 3.17 - -0.99) | −0.61 (− 1.47–0.25) | −1.69 (− 2.75 - -1.13) | −2.06 (− 2.92 - -1.16) |
S3 (21–24 months) | 74 | 10.00 (9.36–10.92) | −1.46 (− 2.16 - -0.77) | −0.74 (− 1.35 - -0.09) | −1.67 (− 2.46 - -0.75) | −1.44 (− 2.36 - -0.64) | 45 | 9.53 (8.62–10.50) | −1.79 (− 3.09 - -1.13) | −0.65 (− 1.84 - -0.06) | −2.12 (− 2.90 - -1.37) | −1.91 (− 2,77 - -0.77) |
S4 (46–48 months) | 58 | 13.65 (12.42–15.00) | −1.30 (− 2.11 - -0.35) | −0.32 (− 0.92–0.32) | − 1.89 (− 2.52 - -1.25) | −1.48 (− 2.23 - -0.7) | 42 | 13.50 (12.00–15.00) | −1.51 (− 2.35 - − 0.39) | -0.39 (− 1.14–0.07) | −2.09 (− 3.23 - -1.31) | −1.76 (− 2.18 - -0.79) |
S5 (60–64 months) | 51 | 16.00 (14.35–18.00) | −1.08 (− 1.91 - -0.06) | − 0.16 (− 1.02–0.28) | −1.78 (− 2.66 - -1.17) | −1.14 (− 1.87 - -0.46) | 43 | 15.65 (13.80–17.57) | −1.51 (− 2.36 - -0.35) | − 0.65 (− 1.58–0.13) | −2.17 (− 3.04 - -1.38) | −1.27 (− 2.10 - -0.71) |
Difference of SDS | Cohort 1 | Cohort 2 |
---|---|---|
SDSdischarge – SDSbirth | ||
Weight | −0.11 (− 0.83–0.37) | −0.15 (− 0.61–0.35) |
Head circumference | 0.48 (− 0.32–1.30) | − 0.20* (− 0.71–0.75) |
Length | N/A | N/A |
BMI | N/A | N/A |
SDSS5 – SDSbirth | ||
Weight | 0.1 (− 0.6–1.0) | 0.0 (− 1.3–0.7) |
Head circumference | −0.9 (− 1.7–0.0) | −0.8 (− 1.7 – − 0.1) |
Length/height | N/A | N/A |
BMI | N/A | N/A |
SDSS5 –SDSdischarge | ||
Weight | 0.3 (−0.5–1.2) | 0.0 (− 0.6–0.7) |
Head circumference | − 1.3 (− 2.1 – − 0.5) | −1.2 (− 1.6–0.1) |
Length/height | 2.0 (1.0–2.8) | 1.8 (1.1–2.4) |
BMI | −1.5 (− 2.2 – − 0.6) | −1.5 (− 2.0 – − 0.7) |
Influence on SDSW | Influence on SDSHC | Influence on SDSL | ||||
---|---|---|---|---|---|---|
r2 = 0.1573 | r2 = 0.3219 | r2 = 0.2070 | ||||
Estimate | p-value | Estimate | p-value | Estimate | p-value | |
Intercept | −5.751 | 0.0322 | −0.5291 | ns | 0.4486 | ns |
Gestational age at birth | 0.1915 | ns | −0.01476 | ns | −0.01206 | ns |
SDS at birth a / at discharge b | 0.4286 | 0.0041 | 0.4930 | 0.0058 | 0.3374 | 0.0004 |
Gender | 0.3009 | ns | 0.7060 | ns | −0.09560 | ns |
Cohort1/2 | −0.3275 | ns | −0.5057 | ns | −0.2198 | ns |
Cumulative parenteral protein intake d1-d28 | −0.0004704 | ns | −0.02922 | 0.0236 | 0.01227 | ns |